162 related articles for article (PubMed ID: 6145498)
1. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.
White FJ; Wang RY
Brain Res; 1984 May; 300(1):161-6. PubMed ID: 6145498
[TBL] [Abstract][Full Text] [Related]
2. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
Crawley JN; Hommer DW; Skirboll LR
Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat.
Debonnel G; Gaudreau P; Quirion R; de Montigny C
J Neurosci; 1990 Feb; 10(2):469-78. PubMed ID: 2137531
[TBL] [Abstract][Full Text] [Related]
4. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
Lane RF; Blaha CD; Phillips AG
Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
[TBL] [Abstract][Full Text] [Related]
5. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
Crawley JN; Stivers JA; Hommer DW; Skirboll LR; Paul SM
J Pharmacol Exp Ther; 1986 Feb; 236(2):320-30. PubMed ID: 3003339
[TBL] [Abstract][Full Text] [Related]
6. Interactions of cholecystokinin and dopamine in the nucleus accumbens.
Wang RY; White FJ; Voigt MM
Ann N Y Acad Sci; 1985; 448():352-60. PubMed ID: 2862829
[No Abstract] [Full Text] [Related]
7. Does cholecystokinin potentiate dopamine action in the nucleus accumbens?
Wang RY; Hu XT
Brain Res; 1986 Aug; 380(2):363-7. PubMed ID: 3756487
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological effects of cholecystokinin: central dopaminergic systems.
Wang RY; White FJ
Prog Clin Biol Res; 1985; 192():95-103. PubMed ID: 4080721
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin antagonist lorglumide reverses chronic haloperidol-induced effects on dopamine neurons.
Jiang LH; Kasser RJ; Wang RY
Brain Res; 1988 Nov; 473(1):165-8. PubMed ID: 3208120
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens.
Vickroy TW; Bianchi BR
Neuropeptides; 1989 Jan; 13(1):43-50. PubMed ID: 2466220
[TBL] [Abstract][Full Text] [Related]
11. The effects of cholecystokinin on the in vivo release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat.
Voigt MM; Wang RY; Westfall TC
J Neurosci; 1985 Oct; 5(10):2744-9. PubMed ID: 4045551
[TBL] [Abstract][Full Text] [Related]
12. Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro.
Voigt M; Wang RY; Westfall TC
J Pharmacol Exp Ther; 1986 Apr; 237(1):147-53. PubMed ID: 3958963
[TBL] [Abstract][Full Text] [Related]
13. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
Weiss F; Ettenberg A; Koob GF
Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
[TBL] [Abstract][Full Text] [Related]
14. Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward.
Vaccarino FJ; Koob GF
Neurosci Lett; 1984 Nov; 52(1-2):61-6. PubMed ID: 6098878
[TBL] [Abstract][Full Text] [Related]
15. Specificity of nucleus accumbens to activities related to cholecystokinins in rats.
Katsuura G; Itoh S; Hsiao S
Peptides; 1985; 6(1):91-6. PubMed ID: 3991366
[TBL] [Abstract][Full Text] [Related]
16. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
Crawley JH
Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward.
Vaccarino FJ; Vaccarino AL
Neurosci Lett; 1989 Feb; 97(1-2):151-6. PubMed ID: 2918999
[TBL] [Abstract][Full Text] [Related]
18. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin.
Liang RZ; Wu M; Yim CC; Mogenson GJ
Brain Res; 1991 Jul; 554(1-2):85-94. PubMed ID: 1681991
[TBL] [Abstract][Full Text] [Related]
19. Receptor selectivity of cholecystokinin effects on mesoaccumbens dopamine neurons.
Kelland MD; Zhang J; Chiodo LA; Freeman AS
Synapse; 1991 Jun; 8(2):137-43. PubMed ID: 1882334
[TBL] [Abstract][Full Text] [Related]
20. Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic neurons: an electrophysiological study in the rat.
Debonnel G; de Montigny C
Synapse; 1988; 2(5):537-45. PubMed ID: 2903570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
